NEW YORK (GenomeWeb News) – German protein structural analysis firm Proteros Biostructures announced today that it has renewed an agreement to provide analysis services to Rigel Pharmaceuticals.
The two companies have been collaborating since 2007 to decipher the structures of several proteins. Under the deal announced today, Proteros will provide X-ray structural analysis of protein compound complexes for specific targets to support Rigel's drug discovery program. Proteros will use its crystallography platform and proprietary technologies to carry out the project.
Financial and other terms of the deal were not disclosed.